Regis Custom Pharma

Regis Technologies, Inc. is a premier US-based small-molecule CDMO for preclinical and commercial products, with combined expertise in process chemistry, manufacturing, solid-state chemistry, analytical development and high-potency API allowing it to seamlessly scale APIs from initial process development through validation and commercial manufacturing, relying on decades of organic synthesis expertise to solve chemistry challenges and accelerate drugs to market.